Structure Therapeutics (GPCR) Accounts Payables (2022 - 2026)

Structure Therapeutics' Accounts Payables history runs 5 years deep, the most recent figure standing at $7.8 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 10.2% year-over-year to $7.8 million; the TTM figure through Mar 2026 stood at $7.8 million (down 10.2% YoY), while the FY2025 annual figure was $13.9 million, up 72.78% from the prior year.
• Accounts Payables was $7.8 million for Q1 2026 at Structure Therapeutics, down from $13.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $17.8 million in Q3 2025 to a low of $2.2 million in Q2 2024.
• Historically, Accounts Payables has averaged $7.7 million across 5 years, with a median of $7.2 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Accounts Payables plunged 61.24% in 2024, then jumped 306.97% in 2025.
• A 5-year view of Accounts Payables shows it stood at $6.0 million in 2022, then decreased by 21.09% to $4.7 million in 2023, then jumped by 69.21% to $8.0 million in 2024, then soared by 72.78% to $13.9 million in 2025, then slumped by 43.58% to $7.8 million in 2026.
• The last three Accounts Payables figures came in at $7.8 million (Q1 2026), $13.9 million (Q4 2025), and $17.8 million (Q3 2025), per Business Quant data.